"Blood culture"

9,951 resultsPro users have access to +470 Systematic Reviews

Filter Results
          • Pro
          • Pro
          • Pro
          • Pro
          • Pro
          • Pro
                    • Pro

                            Clinical Area Pro

                            Further Refinement
                            User Guide

                            User Guide

                            1
                            Kurin Lock for blood culture collection Kurin Lock for blood culture collection Medtech innovation briefing Published: 31 May 2022 www.nice.org.uk/guidance/mib297 pathwaysSummary Summary • The technologytechnology described in this briefing is Kurin Lock. It is used for collecting blood samples for blood culture. • The innovative aspectsinnovative aspects are that the technology diverts and isolates the first flash (about 0.15 ml) of blood, which may contain contaminants that can lead to a false-positive blood culture result. • The intended place in therapyplace in therapy would be when samples for blood culture are needed, as an alternative to standard collection methods. • The main points from the evidencemain points from the evidence summarised in this briefing are from 7 non-randomised
                            2
                            2024INESSS (Quebec)
                            Review Analysis
                            Appears Promising
                            ?
                            Summary - Judicious blood culture use JULY 2024 Judicious blood culture use English summary Une production de l’Institut national d’excellence en santé et en services sociaux (INESSS) 1 SUMMARY Judicious blood culture use Introduction Blood cultures are used to detect and identify microorganisms in the blood and to determine their susceptibility to anti-infectives. They play a major role among microbiological tests, since the presence of pathogenic agents in the blood has a direct impact on morbidity and the risk of death. Reportedly, in practice, most blood cultures are negative, and those that are positive are sometimes contaminated. There are, therefore, various concerns, particularly with regard to the clinical context in which they are ordered and the blood sampling method used. The Direction de
                            Subscribe to Trip PRO for an enhanced experience
                            • Access to millions of Full-text articles where avaliable
                            • Unlock 100,000+ extra articles with Systematic Reviews
                            • Further Filtering Options
                            • No adverts
                            • Advanced Search Ability
                            • Enhanced SmartSearch showing unlimited related articles
                            Read more about Trip PRO
                            3
                            Kurin Lock for blood culture collection Kurin Lock for blood culture collection Medical technologies guidance Published: 3 April 2024 www.nice.org.uk/guidance/mtg77 © NICE 2024. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of-rights).Your responsibility This guidance represents the view of NICE, arrived at after careful consideration and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Kurin Lock for blood culture collection (MTG77)© NICE 2024. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of-rights).Page 2 of23Contents 1
                            4
                            2022NHS England
                            Improving the blood culture pathway – executive summary NHS England » Improving the blood culture pathway – executive summary Skip to main content Cookies on the NHS England websiteWe’ve put some small files called cookies on your device to make our site work.We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use are a member of the public looking for information and advice about coronavirus (COVID-19), including information about the COVID-19 vaccine, go to the NHS website. You can also find guidance and support on the GOV.UK website.Improving the blood culture pathway – executive summaryDocument first published: 29 June 2022 Page updated: 29 June 2022 Topic: Sepsis Publication type: Guidance NHS England’s report
                            5
                            Clinical and economic evaluation of blood culture whole process optimization in critically ill adult patients with positive blood cultures. Optimizing blood culture processing is important to ensure bloodstream infections are accurately diagnosed while minimizing adverse events caused by antibiotic abuse. We evaluated the impact of optimized blood culture processes on antibiotic use, clinical outcomes and economics in intensive care unit (ICU) patients with positive blood cultures. From March 2020 to October 2021, our microbiology laboratory implemented a series of improvement measures, including the clinical utility of Fastidious Antimicrobial Neutralization (FAN® PLUS) bottles for the BacT/Alert Virtuo blood culture system, optimization of bottles reception, graded reports and an upgraded
                            6
                            2024Clinical Infectious Diseases
                            Rapid implementation of blood culture stewardship: institutional response to an acute national blood culture bottle shortage. We describe our approach to addressing a nation-wide supply issue for blood culture bottles. Aerobic blood culture bottles received from our distributor July 1-15, 2024 was <1% of typical usage. Through education and ordering restrictions blood culture designed to minimize
                            7
                            2024PLoS ONE
                            Effect of a blood culture collection bundle on decreasing the contamination rate. In this study, we examined the effect of a bundled approach to blood collection for blood culture on decreasing contamination. Commensal organisms were considered contaminants on the basis of the clinical course if they were recovered from only a single blood draw (set) and if a positive result for two sets was increased during the intervention. Both items were used in most patients requiring blood cultures. Blood collection through a line caused contamination in only one case. The contamination rate decreased significantly from 2.0% to 1.0% after introduction of the bundle approach (3-year control period vs. 2-year bundle period, p<0.001), and a significant decrease in the contamination rate was observed
                            8
                            Clinical outcomes associated with blood-culture contamination are not affected by utilization of a rapid blood-culture identification system. Contaminated blood cultures result in extended hospital stays and extended durations of antibiotic therapy. Rapid molecular-based blood culture testing can speed positive culture detection and improve clinical outcomes, particularly when combined with an antimicrobial stewardship program. We investigated the impact of a multiplex polymerase chain reaction (PCR) FilmArray Blood Culture Identification (BCID) system on clinical outcomes associated with contaminated blood cultures. We conducted a retrospective cohort study involving secondary data analysis at a single institution. In this before-and-after study, patients with contaminated blood cultures
                            9
                            The Significance of FilmArray Blood Culture Identification Panel (FA-BCID) for Managing Patients with Positive Blood Cultures. We analyzed the accuracy and time efficiency of the FilmArray blood culture identification (FA-BCID) panel in identifying the pathogens in positive blood cultures. Two-hundred and seventy-two individuals were randomly assigned as the control ( = 212) and FA-BCID ( = 60
                            10
                            Implementation of a diagnostic stewardship intervention to improve blood-culture utilization in 2 surgical ICUs: Time for a blood-culture change. We compared the number of blood-culture events before and after the introduction of a blood-culture algorithm and provider feedback. Secondary objectives were the comparison of blood-culture positivity and negative safety signals before and after the intervention. Prospective cohort design. Two surgical intensive care units (ICUs): general and trauma surgery and cardiothoracic surgery. Patients aged ≥18 years and admitted to the ICU at the time of the blood-culture event. We used an interrupted time series to compare rates of blood-culture events (ie, blood-culture events per 1,000 patient days) before and after the algorithm implementation with weekly
                            11
                            Investigating the time to blood culture positivity: why does it take so long? Bloodstream infections (BSIs) are one of the most serious infections investigated by microbiologists. However, the time to detect a BSI fails to meet the rapidity required to inform clinical decisions in real time. Blood culture (BC) is considered the gold standard for diagnosing bloodstream infections. However , the time to blood culture positivity can be lengthy. Underpinning this is the reliance on bacteria replicating to a high concentration, which is necessary for the detection using routine blood culture systems. To improve the diagnosis and management of patients with BSIs, more sensitive detection methods are required. The study aimed to answer key questions addressing the delay in BSI detection
                            12
                            2025BMC Infectious Diseases
                            Interrupted-time-series analysis of the impact of COVID-19 pandemic on blood culture utilization in Shanghai. Limited information is available regarding the changes in blood culture utilization following the COVID-19 pandemic. Blood culture utilization rate is a critical indicator of diagnostic efficiency for infectious diseases. This study aims to describe the impact of the COVID-19 pandemic on blood culture utilization rate in Shanghai. We conducted an interrupted time-series analysis based on electronic health records from the Shanghai Changzheng hospital from January 2014 to October 2023. The outcome measure was the rate of blood culture utilization among inpatients with a temperature of ≥ 39.4 °C. The impact of the COVID-19 pandemic on blood culture utilization was quantified by fitting
                            13
                            2025JAMA network open
                            Blood Culture Use in Medical and Surgical Intensive Care Units and Wards. Blood culture (BC) use benchmarks in US hospitals have not been defined. To characterize BC use in adult intensive care units (ICUs) and wards in US hospitals. A retrospective cross-sectional study of BC use in adult medical ICUs, medical-surgical ICUs, medical wards, and medical-surgical wards from acute care hospitals binomial regression models adjusted for unit type, hospital bed size, geographic region, seasonality, and state COVID-19 case load, with random intercepts accounting for clustering at unit and hospital levels. Secondary outcomes included blood culture positivity, single BCs, BC contamination, and minimum threshold for BC use where blood culture positivity would be optimized. A total of 362 327 blood
                            14
                            A randomised non-inferiority trial investigating antibiotic adjustments based on blood culture in acute cholangitis. This study evaluated the adequacy of using blood cultures alone for antibiotic therapy in mild-to-moderate acute cholangitis after adequate biliary drainage. A prospective, multi-centre, non-inferiority, randomised trial was conducted from August 2015 to September 2023 across 12 tertiary hospitals in South Korea. Patients were randomly assigned 1:1 to groups. The control group was administered antibiotics based on blood and bile culture results, whereas the experimental group treated based on blood culture results alone. The primary outcome was the rate of organ failure, assessed by the presence of shock, acute kidney injury, altered mental status, and acute respiratory distress
                            15
                            Navigating the blood-brain barrier: enhancing blood culture practices in the neuro-ICU. This study evaluates the implementation of a blood culture (BCx) algorithm in the neurology ICU (NICU) to reduce BCx event (BCE) rates. Results show a reduction in BCE rates, without increasing adverse outcomes. The findings support the feasibility of BCx algorithms for improving diagnostic stewardship
                            16
                            Daily Surveillance Blood Cultures in Children Supported With Extracorporeal Membrane Oxygenation: Single-Center, Retrospective Cohort Study, 2021-2023. Diagnosing bloodstream infections (BSIs) in patients on extracorporeal membrane oxygenation (ECMO) can be challenging due to circuit-controlled temperature, altered hemodynamics, and questionable reliability of inflammatory markers in critically ill patients. As a result, practice variability exists among ECMO centers regarding routine blood cultures for surveillance of BSI. Our study aimed to evaluate daily surveillance blood cultures in pediatric and neonatal ECMO patients. Retrospective review of daily surveillance blood cultures from January 2021 to July 2023. We evaluated signs, symptoms, and laboratory results in patients
                            17
                            2025Clinical Infectious Diseases
                            Single- versus multiple-sampling strategy for blood cultures in the diagnosis of infective endocarditis: the prospective multicenter UniEndo study. Single-sampling strategy (SSS) for blood cultures (BC) has not been evaluated in infective endocarditis (IE). We assessed the diagnostic performance of SSS vs conventional multi-sampling strategy (MSS) in IE diagnosis. Patients suspected of IE were
                            18
                            2025EBioMedicine
                            Next-generation diagnostics of bloodstream infections enabled by rapid whole-genome sequencing of bacterial cells purified from blood cultures. Blood culture (BC) remains the cornerstone for diagnosis of bloodstream infections (BSI), but the long turn-around time (TAT) hampers timely selection of appropriate chemotherapy. Novel molecular approaches have been developed to provide faster results
                            19
                            2025Clinical Infectious Diseases
                            Epidemiology and Prognostic Factors Associated With Mold-Positive Blood Cultures: 10-Year Data From a French Prospective Surveillance Program (2012-2022). While invasive fusariosis and lomentosporiosis are known to be associated with fungemia, overall data on mold-related fungemia are limited, hampering early management. This study aimed to describe the epidemiology of mold-positive blood cultures. Epidemiological and clinical data on mold-positive blood cultures from 2012 to 2022 were obtained from the RESSIF database. Pseudofungemia was excluded using modified Duthie and Denning criteria. Univariable and multivariable Firth logistical regression was used to study factors associated with 90-day mortality. Fusarium spp accounted for 67.5% of the 80 events, involving predominantly Fusarium
                            20
                            Weekend effect on blood culture contamination: an observational study at a university hospital in Japan. An association between weekend/off-hour care and unfavorable clinical outcomes has been observed, commonly called the "weekend effect." In the present study, we examined whether there was a weekend effect associated with blood culture (BC) contamination, which can lead to inappropriate